SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-20-000150
Filing Date
2020-11-05
Accepted
2020-11-05 16:11:07
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20200930.htm   iXBRL 10-Q 1405030
2 EX-31.1 a2020-q310xqex311.htm EX-31.1 10906
3 EX-31.2 a2020-q310xqex312.htm EX-31.2 10924
4 EX-32.1 a2020-q310xqex321.htm EX-32.1 4946
5 EX-32.2 a2020-q310xqex322.htm EX-32.2 4961
11 abus-20200930_g1.jpg GRAPHIC 56099
  Complete submission text file 0001447028-20-000150.txt   5667029

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20200930.xsd EX-101.SCH 38477
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20200930_cal.xml EX-101.CAL 68088
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20200930_def.xml EX-101.DEF 178059
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20200930_lab.xml EX-101.LAB 451838
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20200930_pre.xml EX-101.PRE 283514
12 EXTRACTED XBRL INSTANCE DOCUMENT abus-20200930_htm.xml XML 927481
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 201290538
SIC: 2834 Pharmaceutical Preparations